Cord Blood CD133 Depleted Mononuclear Cells, Single Donor, Frozen

Mononuclear cells (MNCs) are composed of lymphocytes (T cells, B cells, and NK cells), monocytes, dendritic cells, and stem/progenitor cells. These cells are critical components of the immune system and play key roles in the humoral and cell-mediated immune responses. Mononuclear cells are commonly used in research and clinical applications in the areas of immunology, infectious disease, hematological malignancies, vaccine development, transplant therapy, and high-throughput screening.
Mononuclear cells are separated from umbilical cord blood by means of a density gradient centrifugation protocol. CD133 depleted mononuclear cells are isolated from cord blood by removing the CD133+ population by immunomagnetic separation. The CD133 depleted mononuclear cells contain less than 0.1% CD133+ cells. The presence of CD133+ cells is assessed by flow cytometry prior to cryopreservation. The isolated MNCs can be used to isolate subpopulations or used as a control for donor matched CD133+ stem cell experiments (Please request the CD133 depleted flow-through fraction upon ordering CD133+ stem cells).
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Species | Human |
---|---|
Disease State | Healthy |
Cell and Tissue Source | Cord Blood |
Cell Type | Mononuclear Cells |
Donor Attributes | HIV-, HepB-, HepC- |
Purity | <0.1% CD133+ Cells by Flow Cytometry |
Viability | ≥70% by Flow Cytometry |
Format | Frozen |
Contains | CryoStor™ CS10 (10% DMSO) |
Anticoagulant | CP2D |
Application Area | Research |